Structure−Activity Study of Brassinin Derivatives as Indoleamine 2,3-Dioxygenase Inhibitors
J. Med. Chem., 2006, 49 (2), pp 684–692
DOI: 10.1021/jm0508888
Publication Date (Web): December 17, 2005
Copyright © 2006 American Chemical Society
Abstract
A screen of indole-based structures revealed the natural product brassinin to be a moderate inhibitor of indoleamine 2,3-dioxygenase (IDO), a new cancer immunosuppression target. A structure−activity study was undertaken to determine which elements of the brassinin structure could be modified to enhance potency. Three important discoveries have been made, which will impact future IDO inhibitor development: (i) The dithiocarbamate portion of the brassinin lead is a crucial moiety, which may be binding to the heme iron of IDO; (ii) an indole ring is not necessary for IDO inhibition; and (iii) substitution of the S-methyl group of brassinin with large aromatic groups provides inhibitors that are three times more potent in vitro than the most commonly used IDO inhibitor, 1-methyl-tryptophan.
Citation data is made available by participants in CrossRef's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search in SciFinder.
- Martyn Inman
, Catarina Carvalho, William Lewis, and Christopher J. MoodyThe Journal of Organic Chemistry 2016 81 (17), 7924-7930 - Shu-Yu Lin
, Teng-Kuang Yeh, Ching-Chuan Kuo, Jen-Shin Song, Ming-Fu Cheng, Fang-Yu Liao, Min-Wu Chao, Han-Li Huang, Yi-Lin Chen, Chun-Yu Yang, Mine-Hsine Wu, Chia-Ling Hsieh, Wenchi Hsiao, Yi-Hui Peng, Jian-Sung Wu, Li-Mei Lin, Manwu Sun, Yu-Sheng Chao, Chuan Shih, Su-Ying Wu, Shiow-Lin Pan, Ming-Shiu Hung, and Shau-Hua UengJournal of Medicinal Chemistry 2016 59 (1), 419-430 - Ute F. Röhrig
, Somi Reddy Majjigapu, Pierre Vogel, Vincent Zoete, and Olivier MichielinJournal of Medicinal Chemistry 2015 58 (24), 9421-9437 - Brendan Kelly
, Michela McMullan, Carolina Muguruza, Jorge E. Ortega, J. Javier Meana, Luis F. Callado, and Isabel RozasJournal of Medicinal Chemistry 2015 58 (2), 963-977 - Shuangshuang Yang
, Xishuai Li, Fangfang Hu, Yinlong Li, Yunyun Yang, Junkai Yan, Chunxiang Kuang, and Qing YangJournal of Medicinal Chemistry 2013 56 (21), 8321-8331 
Raffaele Pasceri, David Siegel, David Ross, and Christopher J. MoodyJournal of Medicinal Chemistry 2013 56 (8), 3310-3317- Alka Marwaha
, John White, Farah El_Mazouni, Sharon A Creason, Sreekanth Kokkonda, Frederick S. Buckner, Susan A. Charman, Margaret A. Phillips, and Pradipsinh K. RathodJournal of Medicinal Chemistry 2012 55 (17), 7425-7436 - Emmanuel S. Akinboye
, Marc D. Rosen, Samuel R. Denmeade, Bernard Kwabi-Addo, and Oladapo BakareJournal of Medicinal Chemistry 2012 55 (17), 7450-7459 - M. Soledade C. Pedras
and Vijay K. Sarma-MamillapalleJournal of Agricultural and Food Chemistry 2012 60 (32), 7792-7798 - Ute F. Röhrig
, Somi Reddy Majjigapu, Aurélien Grosdidier, Sylvian Bron, Vincent Stroobant, Luc Pilotte, Didier Colau, Pierre Vogel, Benoît J. Van den Eynde, Vincent Zoete, and Olivier MichielinJournal of Medicinal Chemistry 2012 55 (11), 5270-5290 - Eduard Dolušić
, Pierre Larrieu, Laurence Moineaux, Vincent Stroobant, Luc Pilotte, Didier Colau, Lionel Pochet, Benoît Van den Eynde, Bernard Masereel, Johan Wouters, and Raphaël FrédérickJournal of Medicinal Chemistry 2011 54 (15), 5320-5334 - Arun K. Ghosh
, Jun Takayama, Kalapala Venkateswara Rao, Kiira Ratia, Rima Chaudhuri, Debbie C. Mulhearn, Hyun Lee, Daniel B. Nichols, Surendranath Baliji, Susan C. Baker, Michael E. Johnsonand Andrew D. MesecarJournal of Medicinal Chemistry 2010 53 (13), 4968-4979 - Ute F. Röhrig
, Loay Awad, Aurélien Grosdidier, Pierre Larrieu, Vincent Stroobant, Didier Colau, Vincenzo Cerundolo, Andrew J. G. Simpson, Pierre Vogel, Benoît J. Van den Eynde, Vincent Zoeteand Olivier MichielinJournal of Medicinal Chemistry 2010 53 (3), 1172-1189 - Eddy W. Yue
, Brent Douty, Brian Wayland, Michael Bower, Xiangdong Liu, Lynn Leffet, Qian Wang, Kevin J. Bowman, Michael J. Hansbury, Changnian Liu, Min Wei, Yanlong Li, Richard Wynn, Timothy C. Burn, Holly K. Koblish, Jordan S. Fridman, Brian Metcalf, Peggy A. Scherleand Andrew P. CombsJournal of Medicinal Chemistry 2009 52 (23), 7364-7367 - Dipanwita Batabyal
and Syun-Ru YehJournal of the American Chemical Society 2009 131 (9), 3260-3270 - Sanjeev Kumar
, Daniel Jaller, Bhumika Patel, Judith M. LaLonde, James B. DuHadaway, William P. Malachowski, George C. Prendergastand Alexander J. MullerJournal of Medicinal Chemistry 2008 51 (16), 4968-4977 - Sanjeev Kumar
, William P. Malachowski, James B. DuHadaway, Judith M. LaLonde, Patrick J. Carroll, Daniel Jaller, Richard Metz, George C. Prendergastand Alexander J. MullerJournal of Medicinal Chemistry 2008 51 (6), 1706-1718 - Dipanwita
Systematic study of imidazoles inhibiting IDO1 via the integration of molecular mechanics and quantum mechanics calculations
Yi Zou, Fang Wang, Yan Wang, Wenjie Guo, Yihua Zhang, Qiang Xu, Yisheng LaiEuropean Journal of Medicinal Chemistry 2017 ,An efficient, four-component reaction for the synthesis of novel carbamodithioates
Seyed Esmail Sadat-Ebrahimi, Leila Karim, Setareh Moghimi, Azadeh Yahya-Meymandi, Mohammad Mahdavi, Mohsen Vosooghi, Alireza Foroumadi, Abbas ShafieeJournal of Sulfur Chemistry 2017 38 (1), 43-51The kynurenine pathway and the brain: Challenges, controversies and promises
Robert Schwarcz, Trevor W. StoneNeuropharmacology 2017 112, 237-247Design, synthesis, and preliminary evaluation of the biological activity of dithiocarbamate-3-epi-jaspine B hybrids
En Zhang, Wei-Wei Jiao, Shang Wang, Jin-Mei Xu, Xiao-Jing Shi, Yan-Chao Wang, Ya-Na Wang, Hong-Min LiuMedicinal Chemistry Research 2016 25 (12), 3011-3020Antiproliferative Effect of Indole Phytoalexins
Martina Chripkova, Frantisek Zigo, Jan MojzisMolecules 2016 21 (12), 1626Dithiocarbamate as an efficient intermediate for the synthesis of 2-(alkylthio)thiazol-4(5 H )-ones
Azim Ziyaei Halimehjani, M. Ali Alaei, Farzaneh Soleymani Movahed, Negin Jomeh, Mohammad R. SaidiJournal of Sulfur Chemistry 2016 37 (5), 529-536Docking Studies and Molecular Dynamic Simulations Reveal Different Features of IDO1 Structure
Francesco Antonio Greco, Answald Bournique, Alice Coletti, Chiara Custodi, Daniela Dolciami, Andrea Carotti, Antonio MacchiaruloMolecular Informatics 2016 35 (8-9), 449-459A one-pot three-component synthesis of dithiocarbamates starting from vinyl pyridines and vinyl pyrazine under solvent- and catalyst-free conditions
Azim Ziyaei Halimehjani, Jürgen Martens, Torben SchlüterTetrahedron 2016 72 (27-28), 3958-3965Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy
Aitziber Buqué, Norma Bloy, Fernando Aranda, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo GalluzziOncoImmunology 2016 5 (6), e1149674Discovery of novel heteroarylmethylcarbamodithioates as potent anticancer agents: synthesis, structure-activity relationship analysis and biological evaluation
Ying-Bo Li, Xu Yan, Ri-Dong Li, Peng Liu, Shao-Qian Sun, Xin Wang, Jing-Rong Cui, De-Min Zhou, Ze-Mei Ge, Run-Tao LiEuropean Journal of Medicinal Chemistry 2016 ,Design and synthesis of dithiocarbamate linked β-carboline derivatives: DNA topoisomerase II inhibition with DNA binding and apoptosis inducing ability
Ahmed Kamal, Manda Sathish, V. Lakshma Nayak, Vunnam Srinivasulu, Botla Kavitha, Yellaiah Tangella, Dinesh Thummuri, Chandrakant Bagul, Nagula Shankaraiah, Narayana NageshBioorganic & Medicinal Chemistry 2015 23, 5511-5526Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects
Inkyu Hwang, Nguyet NguyenArchives of Pharmacal Research 2015 38, 1415-1433A novel dithiocarbamate derivative induces cell apoptosis through p53-dependent intrinsic pathway and suppresses the expression of the E6 oncogene of human papillomavirus 18 in HeLa cells
Yanhong Li, Hongxue Qi, Xiaobo Li, Xueling Hou, Xueying Lu, Xiangwen XiaoApoptosis 2015 20, 787-795Dithiocarbamate/piperazine bridged pyrrolobenzodiazepines as DNA-minor groove binders: Synthesis, DNA-binding affinity and cytotoxic activity
Ahmed Kamal, Kokkonda Sreekanth, Nagula Shankaraiah, Manda Sathish, Shalini Nekkanti, Vunnam SrinivasuluBioorganic Chemistry 2015 59, 23-30Discovery of novel AHLs as potent antiproliferative agents
Jing-Li Ren, Xu-Yao Zhang, Bin Yu, Xi-Xin Wang, Kun-Peng Shao, Xiao-Ge Zhu, Hong-Min LiuEuropean Journal of Medicinal Chemistry 2015 93, 321-329Research progress of indoleamine 2,3-dioxygenase inhibitors
Tianze Jiang, Yingying Sun, Zhichao Yin, Sen Feng, Liping Sun, Zhiyu LiFuture Medicinal Chemistry 2015 7 (2), 185-201Targeting the indoleamine 2,3-dioxygenase pathway in cancer
Yong Wha Moon, Joud Hajjar, Patrick Hwu, Aung NaingJournal for ImmunoTherapy of Cancer 2015,Trial watch: IDO inhibitors in cancer therapy
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Catherine Sautès-Fridman, Eric Tartour, Eugene P Kennedy, Michael Platten, Laurence Zitvogel, Guido Kroemer, Lorenzo GalluzziOncoImmunology 2014 3, e957994ROS-Dependent Antiproliferative Effect of Brassinin Derivative Homobrassinin in Human Colorectal Cancer Caco2 Cells
Martin Kello, David Drutovic, Martina Chripkova, Martina Pilatova, Mariana Budovska, Lucia Kulikova, Peter Urdzik, Jan MojzisMolecules 2014 19, 10877-10897Discovery and structure–activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors
Ming-Fu Cheng, Ming-Shiu Hung, Jen-Shin Song, Shu-Yu Lin, Fang-Yu Liao, Mine-Hsine Wu, Wenchi Hsiao, Chia-Ling Hsieh, Jian-Sung Wu, Yu-Sheng Chao, Chuan Shih, Su-Ying Wu, Shau-Hua UengBioorganic & Medicinal Chemistry Letters 2014 24 (15), 3403-3406Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation
Catarina Carvalho, David Siegel, Martyn Inman, Rui Xiong, David Ross, Christopher J. MoodyOrganic & Biomolecular Chemistry 2014 12 (17), 2663The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin
Mariana Budovská, Martina Pilátová, Lenka Varinská, Ján Mojžiš, Roman MezencevBioorganic & Medicinal Chemistry 2013 21 (21), 6623-6633Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 – 2012)
Eduard Dolušić, Raphaël FrédérickExpert Opinion on Therapeutic Patents 2013 23, 1367-1381Design, synthesis and antibacterial evaluation of novel AHL analogues
Jing-Li Ren, En Zhang, Xian-Wei Ye, Meng-Meng Wang, Bin Yu, Wen-Hua Wang, Ya-Zhuo Guo, Hong-Min LiuBioorganic & Medicinal Chemistry Letters 2013 23, 4154-4156Synthesis of S - and N -Functionalized Dithiocarbamates from Cyclic Sulfates
Jose Parada-Aliste, Alicia Megia-Fernandez, Diego De la Torre-Gonzalez, Fernando Hernandez-Mateo, Francisco Santoyo-GonzalezEuropean Journal of Organic Chemistry 2013 2013 (18), 3758-3763Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline
Sheng-Li Cao, Ying Han, Chong-Zhen Yuan, Yao Wang, Zhi-Kai Xiahou, Ji Liao, Rui-Ting Gao, Bei-Bei Mao, Bao-Li Zhao, Zhong-Feng Li, Xingzhi XuEuropean Journal of Medicinal Chemistry 2013 64, 401-409Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole-dithiocarbamate-urea hybrids
Ying-Chao Duan, Yi-Chao Zheng, Xiao-Chen Li, Meng-Meng Wang, Xian-Wei Ye, Yuan-Yuan Guan, Gai-Zhi Liu, Jia-Xin Zheng, Hong-Min LiuEuropean Journal of Medicinal Chemistry 2013 ,Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors
Minoru Tanaka, Xin Li, Hidemasa Hikawa, Takafumi Suzuki, Katsuhiko Tsutsumi, Masashi Sato, Osamu Takikawa, Hideharu Suzuki, Yuusaku YokoyamaBioorganic & Medicinal Chemistry 2013 21 (5), 1159-1165IDO in Immune Escape
Alexander J. Muller, Courtney Smith, Richard Metz, George C. Prendergast2013, 565-581A novel palladium-catalyzed cyclization of indole phytoalexin brassinin and its 1-substituted derivatives
Mariana BudovskáRSC Advances 2013 ,Novel Dithiocarbamic Acid Esters Derived from 6-Aminomethyl-4-anilinoquinazolines and 6-Aminomethyl-4-anilino-3-cyanoquinolines as Potent EGFR Inhibitors
Xin Zhang, Ridong Li, Kang Qiao, Zemei Ge, Liangren Zhang, Tieming Cheng, Runtao LiArchiv der Pharmazie 2013 346, 44-52Kynurenines in the CNS: recent advances and new questions
László Vécsei, Levente Szalárdy, Ferenc Fülöp, József ToldiNature Reviews Drug Discovery 2012 ,Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen
Jason R. Smith, Krystal J. Evans, Adam Wright, Robert D. Willows, Joanne F. Jamie, Renate GriffithBioorganic & Medicinal Chemistry 2012 20 (3), 1354-13632-(5-Fluoro-2,3-dioxoindolin-1-yl)ethyl 4-methylpiperazine-1-carbodithioate
Yao Wang, Hui-Hui Lin, Sheng-Li CaoActa Crystallographica Section E Structure Reports Online 2012 68 (1), o94-o95Novel candesartan derivatives as indoleamine 2,3-dioxygenase inhibitors
Kenji Matsuno, Hiroshi Yamazaki, Yoshinobu Isaka, Kazushige Takai, Yuka Unno, Naohisa Ogo, Yoshinobu Ishikawa, Satoshi Fujii, Osamu Takikawa, Akira AsaiMedChemComm 2012 ,Natural Product-Inspired Pyranonaphthoquinone Inhibitors of Indoleamine 2,3-Dioxygenase-1 (IDO-1)*
David J. A. Bridewell, Jonathan Sperry, Jason R. Smith, Priambudi Kosim-Satyaputra, Lai-Ming Ching, Joanne F. Jamie, Margaret A. BrimbleAustralian Journal of Chemistry 2012 ,Studies of the solvatochromic emission properties of N-aroylurea derivatives II: influence of hydrogen-bonding interactions
Anna Bergen, Cornelia Bohne, Denis Fuentealba, Heiko Ihmels, Jan Willem Bats, Hans-Jörg Deiseroth, Elmar NeumannPhotochemical & Photobiological Sciences 2012 11 (12), 1914The Potential Role of CD133 in Immune Surveillance and Apoptosis: A Mitochondrial Connection?
Renata Zobalova, Katerina Prokopova, Marina Stantic, Michael Stapelberg, Lan-Feng Dong, Stephen J. Ralph, Emmanuel Akporiaye, Jiri NeuzilAntioxidants & Redox Signaling 2011 15 (12), 2989-3002Structure–activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors
Qiang Huang, Maofa Zheng, Shuangshuang Yang, Chunxiang Kuang, Cunjing Yu, Qing YangEuropean Journal of Medicinal Chemistry 2011 46, 5680-5687Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Eduard Dolušić, Pierre Larrieu, Sébastien Blanc, Frédéric Sapunaric, Jenny Pouyez, Laurence Moineaux, Delphine Colette, Vincent Stroobant, Luc Pilotte, Didier Colau, Thierry Ferain, Graeme Fraser, Moreno Galleni, Jean-Marie Frère, Bernard Masereel, Benoît Van den Eynde, Johan Wouters, Raphaël FrédérickEuropean Journal of Medicinal Chemistry 2011 46 (7), 3058-3065Synthesis and in vitro antitumor activity of new butenolide-containing dithiocarbamates
Xiao-Juan Wang, Hai-Wei Xu, Lin-Lin Guo, Jia-Xin Zheng, Bo Xu, Xiao Guo, Chen-Xin Zheng, Hong-Min LiuBioorganic & Medicinal Chemistry Letters 2011 21 (10), 3074-3077Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Eduard Dolušić, Pierre Larrieu, Sébastien Blanc, Frédéric Sapunaric, Bernadette Norberg, Laurence Moineaux, Delphine Colette, Vincent Stroobant, Luc Pilotte, Didier Colau, Thierry Ferain, Graeme Fraser, Moreno Galeni, Jean-Marie Frère, Bernard Masereel, Benoît Van den Eynde, Johan Wouters, Raphaël FrédérickBioorganic & Medicinal Chemistry 2011 19, 1550-1561Synthesis and Structure-Activity Relationships of A Novel Class of Dithiocarbamic Acid Esters as Anticancer Agent
Xueling Hou, Zemei Ge, Tingmin Wang, Wei Guo, Jun Wu, Jingrong Cui, Chingsan Lai, Runtao LiArchiv der Pharmazie 2011 , n/a-n/a2-(2,3-Dioxoindolin-1-yl)ethyl 4-(4-nitrophenyl)piperazine-1-carbodithioate
Yao Wang, Chong-Qing Wan, Sheng-Li Cao, Tingting ZhengActa Crystallographica Section E Structure Reports Online 2010 66 (9), o2243-o2243S-Benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase
Kenji Matsuno, Kazushige Takai, Yoshinobu Isaka, Yuka Unno, Masayuki Sato, Osamu Takikawa, Akira AsaiBioorganic & Medicinal Chemistry Letters 2010 20 (17), 5126-5129Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells
Ting Sun, Xiang-Hua Chen, Zheng-De Tang, Jiong Cai, Xiao-Yan Wang, Shih-Chen Wang, Zhao-Long LiMolecular and Cellular Biochemistry 2010 342 (1-2), 29-34Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation
Alexander J Muller, Laura Mandik-Nayak, George C PrendergastImmunotherapy 2010 2 (3), 293-297Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds
Tiziana Di Pucchio, Silvio Danese, Raimondo De Cristofaro, Sergio RutellaExpert Opinion on Therapeutic Patents 2010 20, 229-250Synthesis of dithiocarbamate by Markovnikov addition reaction in aqueous medium
Azim Ziyaei Halimehjani, Katayoun Marjani, Akram AshouriGreen Chemistry 2010 12 (7), 1306Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Löb, Alfred Königsrainer, Hans-Georg Rammensee, Gerhard Opelz, Peter TernessNature Reviews Cancer 2009 9 (6), 445-452Synthesis and Cytotoxicity Screening of Piperazine-1-carbodithioate Derivatives of 2-Substituted Quinazolin-4(3 H )-ones
Sheng-Li Cao, Yan-Wen Guo, Xian-Bo Wang, Mei Zhang, Yu-Ping Feng, Yu-Yang Jiang, Yue Wang, Qian Gao, Jian RenArchiv der Pharmazie 2009 342 (3), 182-189New promises for manipulation of kynurenine pathway in cancer and neurological diseases
Gabriele CostantinoExpert Opinion on Therapeutic Targets 2009 13, 247-258Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease
Antonio Macchiarulo, Emidio Camaioni, Roberto Nuti, Roberto PellicciariAmino Acids 2009, 219Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors
Hitomi Nakashima, Yoshihiro Uto, Eiji Nakata, Hideko Nagasawa, Kazuhiro Ikkyu, Noriko Hiraoka, Kouichiro Nakashima, Yuki Sasaki, Hiroshi Sugimoto, Yoshitsugu Shiro, Toshihiro Hashimoto, Yasuko Okamoto, Yoshinori Asakawa, Hitoshi HoriBioorganic & Medicinal Chemistry 2008 16 (18), 8661-8669Immune escape as a fundamental trait of cancer: focus on IDO
G C PrendergastOncogene 2008 27 (28), 3889-3900A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase
T Banerjee, J B DuHadaway, P Gaspari, E Sutanto-Ward, D H Munn, A L Mellor, W P Malachowski, G C Prendergast, A J MullerOncogene 2008 27 (20), 2851-2857Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape
Jessica B. Katz, Alexander J. Muller, George C. PrendergastImmunological Reviews 2008 222 (1), 206-221Benzyl N -[2-(1 H -indol-3-yl)ethyl]dithiocarbamate
Nagarajan Vembu, Frank R. Fronczek, Celine Petit, Marc DevocelleActa Crystallographica Section E Structure Reports Online 2008 64 (1), o288-o289Chapter 5.2 Five-membered ring systems: pyrroles and benzo analogs
Erin T. Pelkey, Jonathon S. Russel2008, 135-175Immune-refractory cancers and their little helpers—An extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Jörg Wischhusen, Anne Waschbisch, Heinz WiendlSeminars in Cancer Biology 2007 17 (6), 459-468Differential targeting of tryptophan catabolism in tumors and in tumor-draining lymph nodes by stereoisomers of the IDO inhibitor 1-methyl-tryptophan
Alexander J. Muller, Richard Metz, George C. PrendergastInternational Congress Series 2007 1304, 250-261Cytokine Therapy for Cancer
Seunghee Kim-Schulze, Bret Taback, Howard L. KaufmanSurgical Oncology Clinics of North America 2007 16, 793-818Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO)
Antonio Macchiarulo, Roberto Nuti, Daniele Bellocchi, Emidio Camaioni, Roberto PellicciariBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2007 1774 (8), 1058-1068Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery
Javed A Khan, Farhad Forouhar, Xiao Tao, Liang TongExpert Opinion on Therapeutic Targets 2007 11, 695-705Indoleamine 2,3-Dioxygenase in Immune Escape: Regulation and Therapeutic Inhibition
Alexander J. Muller, George C. Prendergast2007, 347-368Isobrassinin and its analogues: Novel types of antiproliferative agents
Péter Csomós, István Zupkó, Borbála Réthy, Lajos Fodor, George Falkay, Gábor BernáthBioorganic & Medicinal Chemistry Letters 2006 16 (24), 6273-6276Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
Alexander J. Muller, Peggy A. ScherleNature Reviews Cancer 2006 6 (8), 613-625Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides
Jarosław Sączewski, Zdziaław Brzozowski, Franciszek Sączewski, Patrick J. Bednarski, Manuel Liebeke, Maria GdaniecBioorganic & Medicinal Chemistry Letters 2006 16 (14), 3663-3667Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast
Eduardo Vottero, Aruna Balgi, Kate Woods, Stuart Tugendreich, Teri Melese, Raymond J. Andersen, A. Grant Mauk, Michel RobergeBiotechnology Journal 2006 1 (3), 282-288
0 件のコメント:
コメントを投稿